
Clare Nasmyth-Miller
Clare Nasmyth-Miller is a Global Development Leader in late stage development for Hoffmann La-Roche, with 25 years of industry experience working in Pharma clinical trials. For much of her career she has focused on developing medicines for Infectious Diseases, including influenza, hepatitis B and bacteria with antibiotic resistance. She has long standing experience in driving development programs forwards and delivering phase 3 studies, as well as leading health authority interactions and filing submissions, resulting in regulatory approvals including from FDA, EMA, CDE.
Clare holds a Honours degree with an intercalated Masters in Biochemistry, and DPhil in Human Genetics, all from the University of Oxford.